Big Pharma Split Corp.
PRM.TO
TSX
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 314.54% | 319.22% | -123.58% | -122.97% | -126.17% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.76% | -95.67% | 117.01% | 111.54% | 613.66% |
| Change in Net Operating Assets | -- | -- | -82.69% | -83.33% | -100.00% |
| Cash from Operations | -83.86% | -83.51% | 27.21% | 23.98% | 8,433.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 99.46% | 99.46% | -- | -- | -- |
| Issuance of Preferred Stock | 460.49% | 460.49% | 56.80% | 56.80% | -53.20% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 6.87% | 4.81% | 24.92% | 26.79% | 18.25% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.89% | 96.82% | -32.68% | -29.35% | -1,578.21% |
| Foreign Exchange rate Adjustments | 76.92% | 75.00% | -57.14% | -57.14% | 7.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 423.18% | 430.34% | -88.33% | -83.93% | 21.15% |
